The F8 gene gives instructions for factor VIII, a protein that helps blood clot after an injury. This gene helps your body form a stable clot, so if it does not work properly, bleeding can last longer and some people develop hemophilia A, with easy bruising, nosebleeds, or bleeding into joints. Public awareness of the F8 gene has long been linked to hemophilia in European royal families, especially descendants of Queen Victoria.
What is a gene?
Genes are sections of DNA that give your cells instructions for making molecules or directing processes in the body. Some genes carry the code for proteins, the parts of cells that do much of the work. Others mainly regulate when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can read more in the LearnHub.
Overview
F8Gene function
What if the gene works
The F8 gene provides instructions for factor VIII, a protein involved in blood clotting. This protein helps other clotting factors form a stable clot after an injury, which helps limit bleeding.
Risk
What if the gene does not work
Variants in the F8 gene cause hemophilia A, a bleeding condition in which blood does not clot well. Milder variants may cause bleeding mainly after injury or surgery, while more severe variants often lead to earlier, more frequent spontaneous bleeding.
Treatment
What does that mean for your treatment
Pathogenic variants in the F8 gene support use of factor VIII replacement or, in some people, emicizumab to prevent bleeding. The specific F8 variant can help estimate the chance of developing factor VIII inhibitors, which may influence monitoring and whether bypassing medicines or immune tolerance treatment are considered. In mild cases, some variants are linked to a better response to desmopressin.
Conditions associated with F8
Gene function
What if the gene works
After a cut or bruise, your body needs a clot to form in a controlled way. The F8 gene provides instructions for factor VIII, a blood protein that helps blood clot at the right time and place. This is a central part of how the F8 gene helps blood clot during everyday healing.
The F8 gene provides instructions for factor VIII, a blood protein used in clotting. It stays ready in the bloodstream so your body can respond when bleeding starts.
Factor VIII acts as a helper for factor IX, another clotting protein. Together they switch on factor X, which moves the clotting process forward.
This step helps your body make more thrombin, a protein that turns liquid blood into a soft clot. It supports the early plug that covers a small injury while healing begins.
In the bloodstream, factor VIII travels attached to von Willebrand factor, a carrier protein. This helps protect factor VIII and keeps it available when a blood vessel needs repair.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the F8 gene can change how the body makes factor VIII, a clotting protein, by reducing how much is produced, causing the protein to fold poorly, or making it break down sooner. This helps explain how variants influence the F8 gene's function at the cellular level. Milder variants may leave some factor VIII activity, while more severe variants can leave little or none. That difference often shapes whether hemophilia A appears milder or starts earlier and is more pronounced.
How variants are linked to conditions
Pathogenic variants in the F8 gene cause hemophilia A, an inherited bleeding condition. This well-known link between F8 gene variants and hemophilia A can lead to easy bruising, prolonged bleeding after injury or surgery, and, in more severe cases, bleeding into joints or muscles. Different F8 variants are associated with mild, moderate, or severe hemophilia A. Some people who carry an F8 variant, including some females, may also have bleeding symptoms.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply represent normal human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For F8, risk is mostly set by whether a disease-causing change is present and whether someone has one X chromosome or two, so family history matters most. In people living with an F8-related bleeding condition, injuries, surgery, and medicines that thin the blood, such as aspirin, can raise the chance of bleeding.
Inheritance of F8 variants
When people ask how variants of the F8 gene are inherited, the main pattern is X-linked recessive. This means the gene is on the X chromosome, so mothers who carry an F8 variant can pass it to sons, who may have hemophilia A, and to daughters, who may be carriers; fathers pass their X chromosome to all daughters and none of their sons. Some girls and women who carry an F8 variant can also have bleeding symptoms. In some families, the variant is new (de novo) and was not inherited from either parent.
What does my F8 result mean for my family?
F8 changes linked to hemophilia A usually follow an X-linked pattern, so family members on the mother’s side may also carry the change or be affected. Sisters, brothers, daughters, and other close relatives can have different chances of inheriting it, depending on where the result came from in the family. Some cases happen for the first time in one person, so a parent may not always have the same change.
Genetic information
Genetic testing
How you find out about variants
F8 genetic testing looks for variants in the F8 gene using a blood sample or saliva sample. It can help confirm hemophilia A, clarify carrier status, and show whether a family variant is present by reading the gene's DNA code in a laboratory.
When should I consider getting a genetic test?
Consider genetic testing for the F8 gene if there is unexplained easy bruising or prolonged bleeding, a family history of hemophilia A, or if someone in your family already has an F8 change. Testing can help confirm hemophilia A, identify female relatives who may be carriers, and guide family planning.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, although how much it reveals depends on the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect a person’s response to medications. It looks at the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. Understanding this can support treatment decisions that are both more informed and more individualized. If you want to explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the F8 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding most medication choices, so general concerns about medicines or your health are best discussed with your doctor. In people living with F8-related hemophilia A, research shows that some F8 changes are linked to a higher chance of developing antibodies that make factor VIII treatment work less well. Seek medical advice if bleeding is harder to control or treatment seems less effective than before.
History
Throughout history, people have described features that hinted at this gene. Long before the F8 gene was identified, families with a tendency toward prolonged bleeding were recognized in medical writings and family records. Hemophilia A became especially well known through European royal families in the 19th century, which led to the nickname “the royal disease.” In the 20th century, researchers separated hemophilia A from other bleeding conditions and linked it to factor VIII. Building on this early work, scientists identified the F8 gene in the 1980s, a major step that improved genetic testing and family studies. These historical steps shaped today’s understanding of inherited bleeding conditions linked to the F8 gene.